TCT 2022 Late-Breaking Science Collection
Published: 08 September 2022
-
Views:
1920
-
Likes:
7
-
Views:
1920
-
Likes:
7
-
Up Next -
6m 36s
-
4m 10sPart 2 | Session 9 FLASH Trial: US Outcomes of the FlowTriever for Pulmonary Embolism
-
37m 13sPart 1 | Session 1 TCT 22 Late-breaking Science Wrap-up Nicolas M Van Mieghem, Joost Daemen
-
27m 14sPart 1 | Session 2 TCT 22 Late-breaking Science Preview Nicolas M Van Mieghem, Joost Daemen
-
6m 5sPart 2 | Session 1 PROTECTED-TAVR: Sentinel® Stroke Protection System During TAVR Samir R Kapadia
-
5m 12sPart 2 | Session 2 RADIANCE II: Paradise Renal Denervation in Pts With Hypertension Ajay J Kirtane
-
9m 21sPart 2 | Session 3 The AMULET-IDE Study: 3-year Outcomes of the Amulet Left Atrial Appendage Occluder in Patients With Atrial Fibrillation Dhanunjaya Lakkireddy
-
6m 38sPart 2 | Session 4 The PARTNER 3 Trial: SAPIEN 3 Ultra THV For Failed Aortic Bioprosthetic Valves Santiago Garcia
-
7m 21sPart 2 | Session 5 FAME 3: FFR-Guided PCI Vs CABG in Pts With Multivessel CAD Yuhei Kobayashi
-
6m 9sPart 2 | Session 6 The SCOPE I Study: 3-Year Outcomes Comparing ACURATE Neo to SAPIEN 3 in Patients With Severe Aortic Stenosis Jonas Lanz
Overview
Stay up-to-date with our regular review series, View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this #TCT2022 edition they provide a short analysis of the most pertinent data from 15 late-breaking science presentations.
Short, accessible Expert Interviews were conducted with investigators focusing on study design, key results and applicability of the latest data.
More from this programme
Part 1
View from the Thoraxcenter
In this engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) review the most impactful late-breaking science studies from TCT 2022.
Part 2